Is Zhongzhi Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Zhongzhi Pharmaceutical pays dividends. Last time was Thursday 13th of June 2024 where the investors holding the stock on Friday 24th of May 2024 were paid HKD0.032319 per share. Over the last 13 times between 2016 and 2024, Zhongzhi Pharmaceutical has paid HKD0.39977371 with an average of HKD0.03 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Zhongzhi Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD1.280, you would have made a loss of HKD-0.380 per share or -29.69%
No, the average daily trading liquidity for Zhongzhi Pharmaceutical is HKD211 742 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Zhongzhi Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.45, the company's ability to pay off the debt is normal. Zhongzhi Pharmaceutical has a good net profit margin of 7.94% and should have high tolerances against inflation.
We have calculated the inflation risk for Zhongzhi Pharmaceutical to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.